Qiuyun Luo

A novel small molecule inhibitor of MDM2-p53 (APG-115) enhances radiosensitivity of gastric adenocarcinoma

Hanjie Yi, Xianglei Yan, Qiuyun Luo et al. · Journal of Experimental & Clinical Cancer Research · 2018 · 71 citations · Full text

Medicine, Oncology, Pharmacology +16

The BCL-2 inhibitor APG-2575 resets tumor-associated macrophages toward the M1 phenotype, promoting a favorable response to anti-PD-1 therapy via NLRP3 activation

Fan Luo, Han Li, Wenjuan Ma et al. · Cellular and Molecular Immunology · 2023 · 67 citations · Full text

Medicine, Immunology, Oncology +17

A Novel BCL-2 Inhibitor APG-2575 Exerts Synthetic Lethality With BTK or MDM2-p53 Inhibitor in Diffuse Large B-Cell Lymphoma

Qiuyun Luo, Wentao Pan, Suna Zhou et al. · Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics · 2020 · 51 citations · Full text

Medicine, Oncology, Pharmacology +17

Bcl‐2/Bcl‐xl inhibitor APG‐1252‐M1 is a promising therapeutic strategy for gastric carcinoma

Hanjie Yi, Miao‐Zhen Qiu, Luping Yuan et al. · Cancer Medicine · 2020 · 50 citations · Full text

Medicine, Oncology, Pharmacology +17

A novel SMAC mimetic APG-1387 exhibits dual antitumor effect on HBV-positive hepatocellular carcinoma with high expression of cIAP2 by inducing apoptosis and enhancing innate anti-tumor immunity

Wentao Pan, Qiuyun Luo, Xianglei Yan et al. · Biochemical Pharmacology · 2018 · 44 citations

Life Sciences, Oncology, Pharmacology +15